3rd QUARTER 2023
Reporting
Evonik has published its quarterly report Q3 2023 on November 7, 2023.
You can access further information here.
- Adj. EBITDA of €485 m well above Q2 level
- Weak economic environment offset by positive market momentum in Animal Nutrition
and contingency support - Contingency measures on track and to be extended into 2024
- Cash generation picking up strongly with FCF of €469 m in Q3
- Adj. EBITDA outlook for FY 2023 of €1.6 to 1.8 bn confirmed
Reporting 3rd Quarter 2023
|
Document
|
Link / PDF
|
|
Analyst & Investor Factsheet
|
|
|
Presentation Conference Call
|
|
|
Detailed overview of key financial data (Evonik Financials) - as PDF |
|
|
Detailed overview of key financial data (Evonik Financials) - as Excel |
|
|
Quarterly Statement Q3 2023 |
|
|
Investor Relations News Q3 2023 |
|
|
Analysts' consensus* (Vara Research)
|
|
|
Webcast Conference Call Q3 2023 |
* The consensus is not controlled, changed or censored by Evonik Industries AG. Evonik Industries AG assumes no liability for the accuracy and completeness of these estimates and undertakes no obligation to update or revise such estimates and consensus data, even if they differ from Evonik Industries AG’s own forecasts or expectations. Evonik Industries AG is neither involved in the collection of the data, nor in the preparation of the consensus. This is done independently by Vara Research.